West Virginia NP's Drug Rx Rights Yanked by Inaction
Published Date: 7/16/2025
Notice
Summary
Osric Malone Prioleau, a nurse practitioner from West Virginia, lost his DEA registration because he no longer has state permission to handle controlled substances. He didn’t ask for a hearing, so the DEA officially revoked his registration as of early 2025. This means he can’t legally prescribe or manage controlled drugs anymore, effective immediately.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
DEA Registration Revoked for Named Nurse
The Drug Enforcement Administration revoked DEA Certificate of Registration No. MM2233827 issued to Osric Malone Prioleau, N.P., and will deny any pending renewals or other registration applications in West Virginia. The Order is effective August 15, 2025; the record shows his West Virginia nursing licenses were suspended on August 22, 2024 and his DEA registration expired January 31, 2025. Mr. Prioleau may file a properly supported motion for reconsideration of the findings of fact within fifteen calendar days of the date of this Order.
DEA May Revoke When State License Suspended
The DEA states that it may suspend or revoke a practitioner's federal registration under 21 U.S.C. 824(a)(3) when the practitioner’s state license or registration has been suspended or revoked so the practitioner is no longer authorized to handle controlled substances under state law. The Agency also affirms it may adjudicate and enter final orders even where a DEA registration expired before the Order to Show Cause was issued.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-20749, Vladimir Romaniv, P.A.; Decision and Order
The DEA has officially suspended and is moving to revoke Vladimir Romaniv, P.A.'s registration because he gave multiple prescriptions without properly checking on a patient who was in jail. This affects Romaniv’s ability to prescribe controlled substances and signals serious legal trouble starting from late 2025. If you’re connected to his practice or rely on his prescriptions, expect changes and tighter controls soon.
2026-20750, L Krenk DBA Maui Clinic Pharmacy; Decision and Order
The DEA has officially revoked L Krenk DBA Maui Clinic Pharmacy’s registration because they broke important rules about where and how they handled controlled substances. This affects the pharmacy in Kahului, Hawaii, which can no longer legally dispense these drugs. The decision is final, and the pharmacy missed its chance to defend itself, so the revocation takes effect immediately, impacting their business and customers.
Previous / Next Documents
Previous: 2025-13315, Benson Sergiles, P.A.; Decision and Order
Benson Sergiles, P.A., a medical practice in Arizona, lost its DEA registration because it no longer has the state permission to handle controlled substances. Despite multiple attempts, the DEA couldn’t reach them for a hearing, so the registration was revoked by default. This means Benson Sergiles can’t legally manage controlled drugs anymore, effective immediately, impacting their business operations.
Next: 2025-13318, Revised Specification Pursuant to the Personal Responsibility and Work Opportunity Reconciliation Act of 1996
The Attorney General just updated a key rule from 2001 tied to the Personal Responsibility and Work Opportunity Act. This change affects agencies handling work and welfare programs, making sure the rules stay fresh and clear. No big money changes yet, but everyone should watch for new instructions soon.